Glaxosmithkline Share News (GSK)

Reading the technicals: no new Wall Street lows ahead

STOXX 600 up 0.2%

*

Travel names support STOXX as insurers drag

STOXX 600 up 0.2%

*

GSK beats expectations, shingles vaccine bolsters outlook

Q4 profit and sales figures beat forecasts

*

LONDON MARKET OPEN: GSK profit up; Vodafone growth slows; US Fed ahead

(Alliance News) - Stock prices in London opened higher on Wednesday, as investors expect to see the US central bank continue to slow the pace of its interest rate hikes.

TOP NEWS: GSK profit grows as aims for first-ever approved RSV vaccine

(Alliance News) - GSK PLC on Wednesday reported a growth in profit and revenue for 2022 as it looks towards a possible spate of drug approvals for 2023.

CORRECT: Stocks open higher ahead of US Fed rate decision

(Correcting 2021 comparison figure for GSK revenue.)

LONDON BRIEFING: Stocks called higher ahead of US Fed rate decision

(Alliance News) - Stocks in London were set to open higher on Wednesday, following positive leads from Wall Street and Asia, as investors anxiously look ahead to a trio of interest rate decisions this week.

Record vaccine sales boost profits at GSK

(Sharecast News) - Fourth-quarter profits at GSK came in ahead of expectations on Wednesday, boosted by strong demand for the drug giant's blockbuster shingles vaccine.

Haleon appoints Pfizer Chief Financial Officer David Denton to board

(Alliance News) - Haleon PLC on Tuesday said it will add Pfizer Inc Chief Financial Officer David Denton to its board of directors from March 1.

UK earnings, trading statements calendar - next 7 days

Europe's revenue growth expected to slow to a crawl in Q4

LONDON, Jan 24 (Reuters) - Revenue at Europe's largest companies is expected to have risen by just 0.9% in the fourth quarter, Refinitiv I/B/E/S data showed on Tuesday, down from 27.4% in the third quarter and the slowest growth rate since the fourth quarter of 2020.

IN BRIEF: IP Group appoints GSK's Anita Kidgell as non-executive

IP Group PLC - Oxford, England-based intellectual property commercialisation company - Appoints Anita Kidgell as an independent non-executive director, effective from Wednesday. Kidgell is currently head of Corporate Strategy at GSK PLC. GSK is a London-based multinational pharmaceutical and biotechnology company. Says Kidgell will bring a combination of a scientific background together with strategic and communication experience in a listed company.

Moderna says RSV vaccine 84% effective at preventing symptoms in older adults

Jan 17 (Reuters) - Moderna Inc said on Tuesday that its experimental messenger RNA vaccine for respiratory syncytial virus (RSV) was 83.7% effective in a late-stage trial at preventing at least two symptoms, such as cough and fever, in adults aged 60 and older.

Bayer shares gain as another activist investor piles in

FRANKFURT, Jan 11 (Reuters) - Bayer is facing demands from activist investor Bluebell Capital Partners to break up, a person familiar with the matter told Reuters, pushing shares in the diversified health and agriculture group to a five-week high.

U.S. experts recommend weight-loss drugs for obese children

Jan 9 (Reuters) - The American Academy of Pediatrics (AAP) on Monday recommended use of weight-loss drugs in children ages 12 years or older for treatment of obesity, which impacts about 14.4 million kids and adolescents in the United States and can lead to serious health complications.